Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02520154
Title Pembrolizumab in Combination With Chemotherapy in Frontline Ovarian Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

ovarian cancer

Therapies

Carboplatin + Paclitaxel

Pembrolizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.